biomedicina slovenica

pr=Buzdin : 11

  1. Zottel Alja; Jovchevska Ivana; Šamec Neja; Kump Ana; Dall’Olio L. Rapor; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Mlakar Jernej; Nikitin D.; Sorokin M; Buzdin Anton A.; Komel Radovan
    VIM, miR-124-3p and miR-9-5p areoverexpressed in small extracellular vesicles ofglioblastoma cells
    2021 ►
  2. Sorokin Maxim; Raevskiy Mikhail; Zottel Alja; Šamec Neja; Skoblar Vidmar Marija; Matjašič Alenka; Zupan Andrej; Mlakar Jernej; Suntsova Maria; Kuzmin Denis V.; Buzdin Anton A.; Jovchevska Ivana
    Large-scale transcriptomics-driven approach revealed overexpression of CRNDE as a poor survival prognosis biomarker in glioblastoma
    2021 ►
  3. Zottel Alja; Šamec Neja; Kump Ana; Raspor Dall'Olio Lucija; Pužar Dominkuš Pia; Romih Rok; Hudoklin Samo; Mlakar Jernej; Nikitin Daniil; Sorokin Maxim; Buzdin Anton A.; Jovchevska Ivana; Komel Radovan
    Analysis of miR-9-5p, miR-124-3p, miR-21-5p, miR-138-5p, and miR-1-3p in glioblastoma cell lines and extracellular vesicles
    2020 ►
  4. Negro Giulia; Aschenbrenner Bertram; Kranjc Brezar Simona; Čemažar Maja; Cör Andrej; Gašljević Gorana; Sorokin Maxim; Buzdin Anton A.; Callari Maurizio; Kvitsaridze Irma
    Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
    2020 ►
  5. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  6. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Sorokin Maxim; Nikitin Daniil; Buzdin Anton A.; Komel Radovan
    High FREM2 gene and protein expression are associated with favorable prognosis of IDH-WT glioblastomas
    2019 ►
  7. Jovchevska Ivana; Šamec Neja; Zottel Alja; Mlakar Jana; Sorokin M; Buzdin Anton A.; Komel Radovan
    Increased FREM2 gene and protein expression is associated to glioblastoma malignant progression and recurrence
    2019 ►
  8. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Šribar Jernej; Križaj Igor; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Nanobodies and OncoFinder
    2018 ►
  9. Jovchevska Ivana; Zottel Alja; Šamec Neja; Mlakar Jernej; Muyldermans Serge; Buzdin Anton A.; Komel Radovan
    Combination of nanobody proteomics and OncoFinder bioinformatics in glioblastoma research and targeting
    2018 ►
  10. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myers Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Differentially expressed proteins in glioblastoma multiforme identified with a nanobody-based anti-proteome approach and confirmed by OncoFinder as possible tumor-class predictive biomarker candidates
    2017 ►
  11. Jovchevska Ivana; Zupanec Neja; Urlep Žiga; Vranič Andrej; Matos Boštjan; Limbäck-Stokin Clara; Muyldermans Serge; Myres Michael P.; Buzdin Anton A.; Petrov Ivan; Komel Radovan
    Nanobody-based approach for the selection of novel differentially expressed proteins in glioblastoma multiforme and their potential use as biomarkers for class prediction
    2016 ►

New search      Comments      Top of page Institute for Biostatistics and Medical Informatics